Enhanced diagnostic accuracy of contrast-enhanced ultrasound in liver space-occupying lesions: superior sensitivity and specificity over conventional ultrasound.
{"title":"Enhanced diagnostic accuracy of contrast-enhanced ultrasound in liver space-occupying lesions: superior sensitivity and specificity over conventional ultrasound.","authors":"Junfang Wang, Weiwei Shi, Yuanyuan Jiang","doi":"10.62347/BBUT6997","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the clinical value of contrast-enhanced ultrasound (CEUS) in diagnosing liver space-occupying lesions.</p><p><strong>Methods: </strong>A total of 487 patients with liver space-occupying lesions were examined using both conventional ultrasound and CEUS. The diagnostic results from the two methods were compared, with pathological findings used as the gold standard. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the receiver operating characteristic curve were calculated for each method to assess their diagnostic value.</p><p><strong>Results: </strong>Among the 487 lesions, 220 were malignant and 267 were benign. The relative blood flow (rBF) in the arterial phase of malignant lesions was significantly higher than that of benign lesions, while the rBF in the delayed phase was significantly lower (P<0.05). In diagnosing malignant lesions, CEUS had a higher detection rate than conventional ultrasound (75% vs. 43.18%, P<0.001). CEUS also demonstrated a higher diagnostic agreement for lesions ≤1 cm compared to conventional ultrasound (85.16% vs. 49.47%, P<0.001). The accuracy, sensitivity, specificity, PPV, and NPV of CEUS were all higher than those of conventional ultrasound (all P<0.05).</p><p><strong>Conclusion: </strong>CEUS is effective in diagnosing liver space-occupying lesions, with superior sensitivity and specificity compared to conventional ultrasound.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"15 3","pages":"1201-1212"},"PeriodicalIF":3.6000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11982715/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/BBUT6997","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To evaluate the clinical value of contrast-enhanced ultrasound (CEUS) in diagnosing liver space-occupying lesions.
Methods: A total of 487 patients with liver space-occupying lesions were examined using both conventional ultrasound and CEUS. The diagnostic results from the two methods were compared, with pathological findings used as the gold standard. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the receiver operating characteristic curve were calculated for each method to assess their diagnostic value.
Results: Among the 487 lesions, 220 were malignant and 267 were benign. The relative blood flow (rBF) in the arterial phase of malignant lesions was significantly higher than that of benign lesions, while the rBF in the delayed phase was significantly lower (P<0.05). In diagnosing malignant lesions, CEUS had a higher detection rate than conventional ultrasound (75% vs. 43.18%, P<0.001). CEUS also demonstrated a higher diagnostic agreement for lesions ≤1 cm compared to conventional ultrasound (85.16% vs. 49.47%, P<0.001). The accuracy, sensitivity, specificity, PPV, and NPV of CEUS were all higher than those of conventional ultrasound (all P<0.05).
Conclusion: CEUS is effective in diagnosing liver space-occupying lesions, with superior sensitivity and specificity compared to conventional ultrasound.
期刊介绍:
The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.